Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT05412888

Effect of CoQ10 on the Endocrine Function of Skeletal Muscle

Recent studies have also shown that repeated episodes of ischemia, followed by reperfusion (IPC), can contribute to the development of adaptive changes not only in the area of the heart muscle, but also in the structure of the skeletal muscles.

In the project, several research questions will be evaluated e.g. what is the relationship between oxidative stress parameters, uric acid concentration and nitric oxide degradation products in groups of people undergoing two-week training in ischemic training, or what is the relationship between the expression of genes associated with muscle cell growth (e.g. myostatin gene) and the effect of ischemia preconditioning training etc.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

21 year–29 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

About this study

Both in sport and medicine, methods are constantly sought that can significantly contribute to improving the ability of tissues to perform their functions and protecting them from effort-induced damage.

In a wide range of interests, especially in people treated for ischemic changes of cardiovascular diseases, are protocols of tissue preconditioning by transient ischemia which significantly contribute to the increase in blood flow in tissue structure.

Recent studies have also shown that repeated episodes of ischemia, followed by reperfusion (IPC), can contribute to the development of adaptive changes not only in the area of the heart muscle, but also in the structure of the skeletal muscles. There is still a lack of detailed research on genetic conditions related to adaptive changes in this area of interest.

In the project, the following research questions were posed:

  • What is the relationship between oxidative stress parameters, uric acid concentration and nitric oxide degradation products in groups of people undergoing two-week training in IPC training, or 2 weeks of CoQ10 supplementation in the light of non-training and non-supplementation?
  • What is the relationship between two weeks of lower limb ischemia preconditioning training, or CoQ10 supplementation, and the expression of genes associated with the stress response (HSF-1, NF-kB, TNF dependent glass)?
  • What is the relationship between the expression of genes associated with muscle cell growth (e.g. myostatin gene) and the effect of preconditioning training by ischemia?
  • What is the relationship between the expression of genes associated with intracellular metabolism and the effect of CoQ10 supplementation?
  • What is the relationship between the expression of genes encoding enzymes of energy pathways (e.g. GAPDH, LDH) and IPC training or CoQ10 supplementation in the study group?
  • How does IPC training or CoQ10 supplementation affect the expression of genes responsible for membrane transport, and the Hedgehog pathway in muscle cells (including Gli1)?
  • How does IPC training affect the expression of transcription factors: Hif-1-alpha (hypoxia-induced factor) and NF-kB and selected genes dependent on their activity?

HYPOTHESIS The level of gene expression associated with oxidative stress, muscle fiber development, angiogenesis, muscle cell energy, and membrane transport will change under the influence of the use of preconditioning training by deficiency or CoQ10 supplementation

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

- gender (males only),

  • not taking medication during the study,
  • good health (no concomitant injuries),
  • negative history of cardiovascular disorders, autonomic nervous system, mental disorders, cerebrospinal injuries and other diseases that may directly affect the results obtained.

Exclusion criteria

Lack of consent to participate in the research project or negative result of medical examinations.

Treatment and study plan

CoQ10 supplementation

Dietary Supplement

Young men training endurance running will be supplemented with CoQ10

Ischemic preconditioning training

Procedure

Young men training endurance running will undergo IPC training

IPC training combined with CoQ10 supplementation

Dietary Supplement

Young men training endurance running will undergo IPC training combined with CoQ10 supplementation

Sham IPC combined with placebo

Dietary Supplement

Young men training endurance running will undergo sham IPC training combined with placebo supplementation

Primary outcomes

  1. The effects of IPC on physical performance

    Time frame: 8 weeks

    IPC training will be combined with endurance exercise and VO2max and serum Lactate will be measured

  2. The effects of CoQ10 supplementation on physical performance

    Time frame: 8 weeks

    CoQ10 supplementation combined with endurance training will be evaluated for endurance improvement in young men. VO2max, myokines, genes associated with the stress response will be measured

  3. The effects of CoQ10 supplementation and IPC on physical performance

    Time frame: 8 weeks

    CoQ10 supplementation combined with IPC and endurance training will be evaluated for endurance improvement in young men. VO2max, myokines, genes associated with the stress response, ulic acid will be measured

Study contacts

Contact information is provided by the study sponsor or research team.

Jedrzej Antosiewicz

CONTACT

[email protected]

0048 513046412

Jedrzej Antosiewicz

CONTACT

[email protected]

Sponsors and collaborators

Lead sponsor

Medical University of Gdansk

Other

Registry information

Official study title

The Effect of Ischemic Preconditioning and Physical Exercise on the Endocrine Function of Skeletal Muscle - the Effect of CoQ10 Supplementation. In Vivo and in Vitro Studies.

Important dates

Study start
2023
Primary completion
2023
Study completion
2026
First posted
Jun 9, 2022
Registry last updated
Jan 4, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.